DOTAGA-FAP-2286-ALB
DOTAGA-FAP-2286-ALB is a derivative of Rofapitide tetraxetan. DOTAGA-FAP-2286-ALB is a selective fibroblast activation protein (FAP) inhibitor with an IC50 value of 67.5 nM. DOTAGA-FAP-2286-ALB enhances tumor retention via albumin interaction, prolonging blood circulation and improving radiometal complex stability (e.g., with 111In and 225Ac). DOTAGA-FAP-2286-ALB is promising for research of radionuclide therapy (TRT) of FAP-positive solid tumors[1].
Product Specifications
UNSPSC
12352005
Target
Drug Derivative; FAP
Related Pathways
Immunology/Inflammation; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.29
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C91H131IN16O25S3
Molecular Weight
2072.21
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog